Cargando…
结合人口学特征比较国产和原研伊马替尼治疗慢性髓性白血病慢性期患者的有效性和安全性
OBJECTIVES: To compare the efficacy and safety of Chinese generic imatinib with branded imatinib as frontline therapy in adults with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP) (Frontline group) , and to explore the efficacy and safety of Chinese generic imatinib in CML-CP pat...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342368/ https://www.ncbi.nlm.nih.gov/pubmed/31856442 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.11.008 |